Levocetirizine Dihydrochloride
The active substance of Levocetirizine Hasco is levocetirizine dihydrochloride.
Levocetirizine Hasco is an antiallergic medication.
Levocetirizine Hasco is used to treat symptoms associated with:
Levocetirizine Hasco in the form of an oral solution is indicated for use in adults, adolescents, and children from 2 years of age.
Before starting treatment with Levocetirizine Hasco, discuss it with your doctor or pharmacist.
1/6
If you may have difficulty emptying your bladder (in conditions such as spinal cord injury or prostate enlargement), consult your doctor.
Levocetirizine Hasco may exacerbate seizure attacks, so consult your doctor if you have epilepsy or a risk of seizures.
If you are scheduled to undergo allergy testing, ask your doctor if you should stop taking Levocetirizine Hasco a few days before the test. Levocetirizine Hasco may affect the results of allergy tests.
It is not recommended to give Levocetirizine Hasco to infants and young children under 2 years of age.
Tell your doctor or pharmacist about all medications you are currently taking or have recently taken, as well as any medications you plan to take.
Caution should be exercised when taking Levocetirizine Hasco with alcohol or other substances that affect brain function.
Sensitive patients, when taking Levocetirizine Hasco with alcohol or other substances that affect brain function, may experience additional decreased alertness and reaction ability.
Levocetirizine Hasco can be taken during or between meals.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medication.
Some patients treated with Levocetirizine Hasco may experience drowsiness, fatigue, and exhaustion. Exercise caution when driving or operating machinery until you know your reaction to the medication. However, special tests conducted with healthy individuals after taking levocetirizine at the recommended dose did not show an effect on attention, reaction ability, or driving ability.
If you have previously been diagnosed with intolerance to some sugars, consult your doctor before taking the medication.
The medication contains 1.15 mg of sodium benzoate in 1 mL of solution.
Levocetirizine Hasco Contains Propylene Glycol(derived from the aroma)
The medication contains 0.8111 mg of propylene glycol in 1 mL of solution.
The medication contains less than 1 mmol (23 mg) of sodium in 1 mL of solution, which means the medication is considered "sodium-free".
Always take this medication exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
2/6
The recommended dose is:
Adults and adolescents over 12 years: 10 mL of solution once a day.
Kidney and Liver Impairment
In patients with kidney impairment, it may be necessary to reduce the dose of the medication depending on the severity of the kidney disease; in children, the dose should also be adjusted according to body weight; the dose of the medication will be determined by the doctor.
Patients with severe kidney impairment should not take Levocetirizine Hasco.
Patients with liver impairment only should take the usual recommended dose of the medication.
In patients with both liver and kidney impairment, it may be necessary to use a lower dose depending on the severity of the kidney disease; in children, the dose should also be adjusted according to body weight; the dose of the medication will be determined by the doctor.
Elderly Patients (65 Years and Older)
In elderly patients, there is no need to adjust the dose if kidney function is normal.
Children from 6 to 12 years: 10 mL of solution once a day.
Children from 2 to 6 years: 2.5 mL of solution twice a day.
It is not recommended to give Levocetirizine Hasco to infants and young children under 2 years of age.
This medication is for oral use only.
A measuring cup is included with the packaging. The solution can be taken undiluted or diluted in a glass of water. The solution should be drunk immediately after dilution.
Levocetirizine Hasco can be taken during or between meals.
Instructions for use:
3/6
The treatment period depends on the type, duration, and severity of the disease symptoms and is determined by the doctor.
4/6
In adults, in case of taking a higher dose of Levocetirizine Hasco than recommended, drowsiness may occur. In children, initially, there may be excitement and restlessness, especially motor, and then drowsiness.
In case of suspected overdose of Levocetirizine Hasco, consult a doctor who will decide what actions should be taken.
In case of missing a dose of Levocetirizine Hasco or taking a dose lower than recommended by the doctor, do not take a double dose to make up for the missed dose.
Take the next dose at the usual time.
Stopping treatment with Levocetirizine Hasco should not cause harmful effects. However, in rare cases, itching (intense itching) may occur after stopping treatment with Levocetirizine Hasco, even if these symptoms did not occur before starting treatment. These symptoms may resolve on their own. In some cases, these symptoms may be intense and it may be necessary to resume treatment.
These symptoms should resolve after resuming treatment.
If you have any further questions about taking this medication, ask your doctor or pharmacist.
Like all medications, Levocetirizine Hasco can cause side effects, although not everybody gets them.
Swelling of the Lips, Tongue, Face, and (or) Throat,
Difficulty Breathing or Swallowing (Chest Tightness or Wheezing),
Hives, Sudden Drop in Blood Pressure Leading to Fainting or Shock, Which
May Lead to Death.
Common: May Occur in Less Than 1 in 10 Patients
Dry Mouth, Headache, Fatigue, and Drowsiness
Uncommon: May Occur in Less Than 1 in 100 Patients
Exhaustion and Abdominal Pain
Frequency Not Known: Cannot be Estimated from the Available Data
Other side effects have also been reported, such as: palpitations, increased heart rate, seizures, tingling, dizziness, fainting, tremors, taste disturbances (altered taste perception), feeling of spinning or swaying, vision disturbances, blurred vision, rotational eye movements (uncontrolled circular eye movement), painful or difficult urination, inability to fully empty the bladder, swelling, itching, rash, hives (swelling, redness, and itching of the skin), skin eruptions, shortness of breath, weight gain, muscle pain, joint pain, excitement and aggressive behavior, hallucinations, depression, insomnia, recurring suicidal thoughts or interest in suicide, nightmares, hepatitis, abnormal liver function, vomiting, increased appetite, nausea, and diarrhea. Itching (intense itching) after stopping treatment with Levocetirizine Hasco.
5/6
If you experience any side effects, including any not listed in this package leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw,
phone: 22 49 21 301, fax: 22 49 21 309.
Website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medication.
Store in a temperature below 25°C. Store in the original packaging.
Shelf life after first opening the bottle: 6 months.
Keep the medication out of sight and reach of children.
Do not use this medication after the expiration date stated on the packaging. The expiration date refers to the last day of the given month.
Medications should not be disposed of via wastewater or household waste containers. Ask your pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
Levocetirizine Hasco is a clear and colorless solution placed in a 200 mL brown glass bottle (type III) containing at least 200 mL of product. The bottle is closed with a high-density polyethylene cap with a polyethylene insert and a tamper-evident seal. The packaging includes a 10 mL polypropylene oral measuring cup with a high-density polyethylene plunger in a set with a polyethylene plug.
“PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK” S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
Medication Information
phone: 22 742 00 22
e-mail: informacjaoleku@hasco-lek.pl
6/6
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.